delgocitinib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for delgocitinib, covering 2025-01-20 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris [Phase 2]